Company Of The Day: Walmart

+3.30%
Upside
133
Market
137
Trefis
WMT: Walmart logo
WMT
Walmart

What?

Retail behemoth Walmart (NYSE:WMT) plans to launch its own brand of insulin called ReliOn, which will be available at Walmart pharmacies this week and at Sam’s Club pharmacies by mid-July.

Why?

Relevant Articles
  1. Is There Upside To Walmart’s Stock?
  2. Company Of The Day: Walmart
  3. Is Walmart’s Stock A Safe Bet?
  4. Walmart Stock To Trade Higher Post Q4?
  5. Should You Buy Walmart’s Stock?
  6. Forecast Of The Day: Sam’s Club Revenue Per Square Foot

Prices for insulin have been surging, proving a financial burden on people with diabetes. Walmart claims that its insulin could be between 58% to 75% cheaper versus branded products.

So What?

Walmart is looking to play a bigger role in the affordable healthcare space, with plans to open over 4000 clinics by 2029. Selling its own branded insulin could be a good starting point, given that the drug is relatively expensive and widely used.

See Our Complete Analysis For Walmart

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market since 2016

See all Trefis Price Estimates and Download Trefis Data here

What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams